Steven I Sherman

12PUBLICATIONS

76CO-AUTHORS

Epidemiological modellingMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursMajor global burdens of disease

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jul 02, 2026

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

|Feb 20, 2026

Acquired Driver Fusions as a Mechanism of Resistance to Selective RET Inhibitors in Advanced Medullary Thyroid Carcinoma.

Sarah Hamidi, Vivek Subbiah, Maria E Cabanillas

|Dec 19, 2025

Increasing Access and Quality Care for Immune Checkpoint Inhibitor-Related Thyroid Dysfunction.

Anne K Brinkman, Amori Y Salami-Henry, Lori A Aaron-Brija

|Aug 12, 2025

Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.

Rozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd

|Jun 26, 2025

Characterization of Advanced RAS-driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues.

Sarah Hamidi, Anastasios Maniakas, Neal S Akhave

|Feb 21, 2025

<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy.

Vicente R Marczyk, Sasan Fazeli, Ramona Dadu

Pageof 2

Frequent Collaborators

Mimi I Hu

Maria E Cabanillas

Steven G Waguespack

Naifa L Busaidy

Mark Zafereo

Sarah Hamidi

Anastasios Maniakas

Sinchita Roy-Chowdhuri

2 joint publications

Rozita Bagheri-Yarmand

2 joint publications

Vicente R Marczyk

Frequent Collaborators

Mimi I Hu

Maria E Cabanillas

Steven G Waguespack

Naifa L Busaidy